Related Experiment Videos
Acetate-free biofiltration in acute renal failure
C Meloni1, M Morosetti, L Meschini
1Istituto Tipizzazione Tissutale, CNR, L'Aquila, Italy.
Artificial Organs
|March 1, 1993
Summary
Acetate-free biofiltration offers a safe and effective hemodialysis strategy for acute renal failure patients, ensuring cardiovascular stability and excellent correction of imbalances. This individualized approach minimizes adverse reactions.
Area of Science:
- Nephrology
- Critical Care Medicine
Background:
- Hemodialysis for acute renal failure (ARF) frequently causes adverse reactions.
- Achieving hemodynamic stability and correcting metabolic imbalances are key treatment goals.
Purpose of the Study:
- To evaluate acetate-free biofiltration (AFB) as an individualized treatment for isolated acute renal failure.
- To assess the safety and efficacy of AFB in patients with diverse ARF etiologies.
Main Methods:
- AFB was used in 26 patients with isolated ARF over 411 dialyses.
- The study monitored for symptomatic treatments, cardiovascular stability, and correction of fluid, electrolyte, and acid-base balance.
Main Results:
- AFB demonstrated an extremely low incidence of symptomatic treatments.
- Remarkable cardiovascular stability was observed throughout the treatment period.
- Excellent correction of fluid, electrolyte, and acid-base imbalances was achieved with adequate dialytic efficacy.
Conclusions:
- Acetate-free biofiltration is a safe and effective technique for hemodialysis in isolated ARF.
- AFB is suitable for individualized treatment, adaptable to patient needs.
- This method offers a valuable alternative for managing acute renal failure patients.